1-16 of 16
Sort by
News

Does High-Dose Methotrexate Protect the Central Nervous System in High-Risk DLBCL?

Published: 2021
View News titled, Does High-Dose Methotrexate Protect the Central Nervous System in High-Risk DLBCL?
News

Azacitidine Maintenance Fails to Improve Post-Transplant Outcomes in High-Risk AML and MDS

Published: 2021
View News titled, Azacitidine Maintenance Fails to Improve Post-Transplant Outcomes in High-Risk AML and MDS
News

FDA Approves Ponatinib for Chronic-Phase CML

Published: 2021
View News titled, FDA Approves Ponatinib for Chronic-Phase CML
News

Selinexor Combination Approved for Patients with Multiple Myeloma

Published: 2021
View News titled, Selinexor Combination Approved for Patients with Multiple Myeloma
News

Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms

Published: 2021
View News titled, Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms
News

Devimistat Receives FDA Fast Track Designation for AML

Published: 2021
View News titled, Devimistat Receives FDA Fast Track Designation for AML
News

Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma

Published: 2021
View News titled, Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma
News

Rethinking Autoimmune Neutropenia in Children

Published: 2021
View News titled, Rethinking Autoimmune Neutropenia in Children
News

Registry Analysis Finds Patients With Hematologic Malignancies Are Highly Vulnerable to COVID-19

Published: 2021
View News titled, Registry Analysis Finds Patients With Hematologic Malignancies Are Highly Vulnerable to COVID-19
News

NIH’s ACTIV Trial Suspends Enrollment of Critically Ill Patients With COVID-19

Published: 2021
View News titled, NIH’s ACTIV Trial Suspends Enrollment of Critically Ill Patients With COVID-19
News

FLAG-IDA Plus Venetoclax Associated With High Response Rates in Acute Myeloid Leukemia

Published: 2021
View News titled, FLAG-IDA Plus Venetoclax Associated With High Response Rates in Acute Myeloid Leukemia
News

There’s No Crime Like the Presents

Published: 2021
View News titled, There’s No Crime Like the Presents
News

Discontinuing Eculizumab is Safe and Feasible in Patients With Atypical Hemolytic Uremic Syndrome

Published: 2021
View News titled, Discontinuing Eculizumab is Safe and Feasible in Patients With Atypical Hemolytic Uremic Syndrome
News

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

Published: 2021
View News titled, Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma
News

Big Ideas on Burnout: Trainees Propose System-Wide Solutions

Published: 2021
View News titled, Big Ideas on Burnout: Trainees Propose System-Wide Solutions
News

BTK Inhibitor LOXO-305 Shows Promise in Previously Treated Mantle Cell Lymphoma

Published: 2021
Abstract
January 2021
View News titled, BTK Inhibitor LOXO-305 Shows Promise in Previously Treated Mantle Cell Lymphoma